Skip to main content
OpenTrials
Completed

NCT Number: NCT02173444

Comparison of the Accuracy and Reliability of AMH, FSH and AFC in Predicting Ovarian Response

Serum bio-markers have different prediction values for ovarian response during ovarian stimulation in-vitro fertilization

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

An Sinh Hospital

Ho Chi Minh City, Ho Chi Minh, Vietnam

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≤ 45 years at the time of FSH starting
  • BMI < 25 kg/m2,
  • First IVF attempt
  • Receiving GnRH-antagonist protocol
  • Had oocyte retrieval

Exclusion criteria

  • Had ovarian stimulation or ovulation induction within 2 months prior to the study
  • PCOS
  • Had ovarian tumor or endometrioma
  • Hyperprolactinemia
  • Thyroid hormone disorders
  • Pituitary failure
  • Had other medical situations such as liver failure, renal failure, heart disease, diabetes, depression
  • Had IVM

Treatment and study plan

Blood Test

Other

Primary outcomes

  1. Number of oocytes

    Time frame: At the time of oocyte retrieval

  2. number of oocytes at time of oocyte retrieval

    Time frame: up to 14 days

Sponsors and collaborators

Lead sponsor

Vietnam National University

Other

Registry information

Acronym: AMH FSH AFC

Important dates

Study start
2013
Primary completion
2013
First posted
Jun 25, 2014
Registry last updated
Jun 25, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.